VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $174,348,000 | +120.1% | 9,069,278 | +82.3% | 0.10% | +9.2% |
Q1 2018 | $79,213,000 | -64.2% | 4,975,689 | -53.3% | 0.09% | -64.3% |
Q4 2017 | $221,332,000 | +223.1% | 10,651,189 | +122.8% | 0.24% | +201.2% |
Q3 2017 | $68,505,000 | +64.8% | 4,780,500 | +99.0% | 0.08% | +52.8% |
Q2 2017 | $41,574,000 | -1.7% | 2,402,589 | -17.5% | 0.05% | -20.9% |
Q4 2016 | $42,294,000 | +298.3% | 2,913,089 | +573.6% | 0.07% | +252.6% |
Q3 2016 | $10,618,000 | +371.3% | 432,489 | +286.5% | 0.02% | +375.0% |
Q2 2016 | $2,253,000 | -90.6% | 111,889 | +3.8% | 0.00% | -92.7% |
Q2 2015 | $23,942,000 | -74.7% | 107,789 | -77.3% | 0.06% | -72.6% |
Q1 2015 | $94,465,000 | +1592.9% | 475,837 | +1120.4% | 0.20% | +1446.2% |
Q4 2014 | $5,580,000 | -10.3% | 38,989 | -17.4% | 0.01% | -13.3% |
Q1 2014 | $6,218,000 | -85.5% | 47,189 | -87.0% | 0.02% | -85.3% |
Q4 2013 | $42,756,000 | – | 364,189 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |